Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
Clinical trial NCT05660135 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05660135
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-20
- Primary completion
- 2024-11-30
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.